Articles tagged with: Keith Alcorn

Diabetes in people with HIV over 50 overwhelmingly linked to old antiretrovirals, not age or body weight

published: January, 04, 2018 Written by // Guest Authors - Revolving Door Categories // Aging, Social Media, Research, Health, International , Revolving Door, Guest Authors, Media

The onset of diabetes was much less likely in people aged 50 and over who started treatment from 2010 onwards, or who started treatment at a higher CD4 cell count, according to this B.C.study. From AIDSmap, Keith Alcorn explains.

Diabetes in people with HIV over 50 overwhelmingly linked to old antiretrovirals, not age or body weight

People with HIV over the age of 50 are more likely to have developed type 2 diabetes if they started antiretroviral treatment before 1999 or had a longer exposure to older antiretroviral drugs such as stavudine (d4T) or first-generation protease inhibitors such as nelfinavir or indinavir, according to a study of people receiving HIV care in British Columbia, Canada. The onset of diabetes was much less likely in people aged 50 and over who started treatment from 2010 onwards, or who started tr

People with high viral load most likely to report sex that could pass on HIV

published: December, 19, 2017 Written by // Guest Authors - Revolving Door Categories // African, Caribbean and Black, Social Media, As Prevention , Gay Men, Treatment Guidelines -including when to start, Health, Revolving Door, International , Treatment, Guest Authors, Media

Half of those most likely to pass on HIV were not on treatment, despite guidelines From AIDSmap, Keith Alcorn reports

People with high viral load most likely to report sex that could pass on HIV

People with HIV who had high viral load were more likely to report vaginal or anal sex without a condom with a partner of unknown or different HIV status, a US study of people with detectable viral load has found. Viral loads tended to be lower among those people with a detectable viral load who reported always using condoms, or who reported condomless sex only with other people with HIV. The findings are published in the journal Sexually Transmitted Infections by a research team led by Dr

Smokers with HIV doing well on treatment now at greater risk of lung cancer than AIDS

published: September, 25, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, Gay Men, Health, Revolving Door, International , Smoking Cessation , Guest Authors, Living with HIV, Media

Just under 60,000 people living with HIV are likely to die of lung cancer by the age of 80 (9.3% of all people with HIV currently in care in the United States), researchers estimate. From AIDSmap, Keith Alcorn reports.

Smokers with HIV doing well on treatment now at greater risk of lung cancer than AIDS

People living with HIV on antiretroviral treatment with fully suppressed viral load who smoke are much more likely to die of lung cancer than HIV-related causes, according to the findings of a modelling study published today in JAMA Internal Medicine. The study suggests that people on successful antiretroviral treatment are between six and thirteen times more likely to die of lung cancer than of any AIDS-related illness, and 10% of all people with HIV who are linked to care will eventually

World on track to reach the 90-90-90 targets for HIV treatment by 2020

published: July, 25, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , Current Affairs, General Health, Treatment Guidelines -including when to start, Mental Health, Research, Sexual Health, Health, Revolving Door, International , Treatment, Guest Authors, Media

The world has passed a tipping point in progress towards the 90-90-90 targets, according to UNAIDS Executive Director Michel Sidibé. From AIDSmap, Keith Alcorn reports.

World on track to reach the 90-90-90 targets for HIV treatment by 2020

The world is on track to reach to reach global targets for reducing AIDS deaths and HIV treatment access by 2020, but some regions of the world risk falling further behind due to lack of political commitment, UNAIDS announced in the run-up to the 9th International AIDS Society Conference on HIV Science, which opened today in Paris. More than half of all people living with HIV (53%) now have access to HIV treatment and AIDS-related deaths have almost halved since 2005, UNAIDS reports in Endi

NAM's director talks about PrEP and the decline in HIV diagnoses on BBC2's Newsnight

published: April, 10, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , Gay Men, General Health, Treatment Guidelines -including when to start, Sexual Health, Health, International , Revolving Door, Treatment, Guest Authors

From AIDSmap, NAM executive director Matthew Hodson: "If you roll it out to everyone who will benefit most, then we have the power to end the epidemic."

NAM's director talks about PrEP and the decline in HIV diagnoses on BBC2's Newsnight

NAM’s Executive Director, Matthew Hodson, appeared on BBC2’s Newsnight on Tuesday 21 February to talk about PrEP (pre-exposure prophylaxis) and the dramatic decline in new HIV diagnoses in London in the past year. In the film sequence accompanying the interview, HIV consultant Dr Nneka Nwokolo of London’s 56 Dean St clinic explained that the reduction in new HIV diagnoses is real, substantial and is being seen in clinics across London. “The most significant thing that’s happene

Implants and injectables: PrEP in the future

published: January, 25, 2017 Written by // Guest Authors - Revolving Door Categories // African, Caribbean and Black, Social Media, As Prevention , Gay Men, Treatment Guidelines -including when to start, Women, Research, International , Revolving Door, Treatment, Guest Authors

Is the future all about implants, or will it offer multiple options for people who want to use PrEP? For AIDSmap.com, Keith Alcorn reports on several developments in PrEP delivery.

Implants and injectables: PrEP in the future

Last month’s announcement that the Bill and Melinda Gates Foundation will give up to $140 million to a Boston drug device manufacturer to develop an implantable mini-pump to deliver drugs for pre-exposure prophylaxis (PrEP) against HIV infection has focused attention on the future of PrEP. Is the future all about implants, or will it offer multiple options for people who want to use PrEP? Implants and other long-acting drug delivery systems have attracted interest as a means of delivering P

Smoking more harmful than HIV for people taking effective treatment, US study suggests

published: November, 17, 2016 Written by // Guest Authors - Revolving Door Categories // Current Affairs

Dr Rochelle Walensky: "It is time to recognise that smoking is now the primary killer of people with HIV who are receiving treatment." For AIDSmap, Keith Alcorn reports.

  Smoking more harmful than HIV for people taking effective treatment, US study suggests

Smoking has the potential to shorten the life of a person taking HIV treatment by an average of six years, and is far more harmful to the life expectancy of people living with HIV than well-managed HIV infection itself, a US study reports this month in the Journal of Infectious Diseases. The study found that stopping smoking improved life expectancy, with the greatest gain in life expectancy seen when smoking was stopped by the age of 40. Dr Rochelle Walensky of the Massachusetts General Ho

HIV drug costs: potential for 90% reduction in costs coming soon?

published: November, 11, 2016 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , Conferences, Treatment Guidelines -including when to start, Health, International , Revolving Door, Treatment, Guest Authors

Insurers in the United States are liable to pay up to four times the price paid by the UK’s NHS for branded antiretrovirals. From AIDSmap.com, Keith Alcorn of thebody.com on the need for more pricing transparency.

HIV drug costs: potential for 90% reduction in costs coming soon?

This article by Keith Alcorn previously appeared at AIDSmap.com, here. The costs of making drugs to treat viral hepatitis, HIV and tuberculosis (TB) are now so low that each disease could be treated for less than $90, Dr Andrew Hill of St Stephen’s AIDS Trust told the opening plenary of the International Congress on Drug Therapy in HIV Infection (HIV Glasgow) on Sunday in Glasgow. The cost of generic drugs to cure TB is already below $90 for a six-month treatment course, and some anti

Media reports of a British HIV cure 'breakthrough' are premature

published: October, 11, 2016 Written by // Guest Authors - Revolving Door Categories // Social Media, Gay Men, Current Affairs, Newly Diagnosed, Research, Health, Revolving Door, International , Guest Authors

From AIDSmap.com, Keith Alcorn reports on the RIVER study and yesterday's clarification.

Media reports of a British HIV cure 'breakthrough' are premature

The Sunday Times yesterday reported that HIV had become undetectable in the blood of one man taking part in the RIVER study, a trial of an intensive treatment regimen designed to test whether it is possible to reduce levels of HIV-infected cells in the bodies of people recently infected with HIV. The researchers hope that the treatment may eradicate HIV infection altogether. The Sunday Times reported that British scientists are on the “brink of an HIV cure”. In fact, the study is

Homophobia and PrEP in the UK

published: August, 09, 2016 Written by // Megan DePutter Categories // Social Media, As Prevention , Gay Men, Current Affairs, Treatment Guidelines -including when to start, International , Legal, Treatment, Megan DePutter, Opinion Pieces

Homophobia and HIV stigma run high in the UK, with the Daily Mail leading the charge, as Megan Deputter relates.

Homophobia and PrEP in the UK

The Daily Mail has published some rubbish in its time, but yesterday’s news takes the cake. One of the first things I did since starting my new role as Training Manager at Terrence Higgins Trust Scotland is develop an HIV Awareness training course. In my introduction to the topic, I provide an overview to where we are with HIV today. In a nutshell, I explain, we have grown immensely in our ability to understand, prevent and treat HIV. But stigma is stubborn. Stigma has been with us since th

[12  >>